Trial · NCT03643406
The Effect of Mental Fatigue on Lower Limb Functional Performance Tests and Brain Activity in a Healthy Population
NCT03643406, Not applicable, Completed, Vrije Universiteit Brussel
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. The Effect of Mental Fatigue on Lower Limb Functional Performance Tests and Brain Activity in a Healthy Population. Trials, record NCT03643406. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT03643406
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- The Effect of Mental Fatigue on Lower Limb Functional Performance Tests and Brain Activity in a Healthy Population
- NCT number
- NCT03643406
- Status
- Completed
- Phases
- Not applicable
- Enrollment
- 13 participants, actual
- Lead sponsor
- Vrije Universiteit Brussel
- Conditions
- Mental Fatigue, Return to Sport, EEG, Brain Activity, Functional Performance
- Interventions
- Mental Fatigue, Control
- First posted
- 2018-08-22
- Last updated
- 2019-07-19
Source ClinicalTrials.gov
Registered outcomes8
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Single-leg hop test | Change in single-leg hop test for distance performance: from baseline and 120 minutes after baseline (immediately after the flanker task) | Single-leg hop test for distance performance |
| Primary | Vertical jump test | Change in vertical jump height performance: from baseline and 120 minutes after baseline (immediately after the flanker task) | Vertical jump height performance |
| Primary | Y-balance test | Change in Y-balance performance: from baseline and 120 minutes after baseline (immediately after the flanker task) | Balance and reach performance; participants have to maintain their balance while reaching as far as possible along 3 different directions. |
| Primary | Balance-reaction time test | Change in balance and reaction time performance: from baseline and 120 minutes after baseline (immediately after the flanker task) | Balance and reaction time performance; participants have to maintain their balance while reacting as fast as possible in 3 different directions. |
| Primary | EEG power spectrum analysis | Change in EEG power spectrum: from baseline and 120 minutes after baseline (immediately after the flanker task) | Brain activity during the Y-balance test, balance-reaction time test and flanker task will be registered at baseline and immediately after the flanker task |
| Secondary | Mental fatigue Visual Analogue Scale (M-VAS) | Change in M-VAS: at baseline, 20 min after baseline (immediately after the first test battery), 120 min after baseline (immediately after the second flanker task) and 135 min after baseline (immediately after the final test battery) | Subjective measure of mental fatigue (0-10cm; 0 = no mental fatigue; 10 = maximal mental fatigue) |
| Secondary | Flanker task | Change in flanker task: at baseline and 90 minutes after baseline (immediately after the mental fatiguing task) | Objective measure of mental fatigue; reaction time and accuracy give an objective indication of mental fatigue |
| Secondary | 90-minute stroop task | Change in reaction time and accuracy will be assessed with a 90-min cognitive task; Reaction Time and Accuracy during the 90-min task will be reported as mean reaction time and accuracy during 8 blocks of 11min15sec | 90 minutes mental fatiguing task; reaction time and accuracy give an objective indication of mental fatigue |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests2
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
| Test | Named as | Source |
|---|---|---|
| Eriksen Flanker Task | Primary outcome | ConductCognition |
| Stroop Color-Word Test | Secondary outcome | ConductCognition |
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT03643406
GET https://conductscience.org/api/trials/v1/NCT03643406/registered